NHS
In Brief This Week: Genomate Health, Aspira Women’s Health, U of Adelaide, Illumina, Asklepios
News items for the week of Nov. 4, 2024.
Cambridge University Hospitals Net £1.5M Grant to Develop Cell Therapy Hub in Eastern England
The funding will allow CUH to buy new equipment for administering treatments such as CAR T-cell therapies, reducing patients' need to travel long distances.
NICE Declines to Recommend Menarini's Orserdu in ESR1-Mutant Breast Cancer in England
In a draft guidance, the institute did not recommend Orserdu, but is collecting additional data and public comments on this preliminary decision.
ABPI Issues Recommendations for UK to Prepare for New Cell, Gene Therapies
The trade group said the UK should prepare for therapies that aim to treat larger patient populations, which could necessitate new payment approaches.
UK's MHRA Approves Astellas' Vyloy for CLDN18.2-Positive Gastric Cancer
The approval is based on two trials in which Vyloy plus chemo bested chemo and placebo in advanced CLDN18.2-positive, HER2-negative gastric cancer.